Virpax Pharmaceuticals Inc (VRPX) — Tangible Net Worth Ratio
Virpax Pharmaceuticals Inc (VRPX) has a Tangible Net Worth Ratio of 100.0% as of December 2023. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.93 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Virpax Pharmaceuticals Inc (VRPX) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Virpax Pharmaceuticals Inc Tangible Net Worth Ratio (2021–2023)
This chart shows how Virpax Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 3 annual periods from 2021 to 2023. As of December 2023, the ratio stands at 100.0%, reflecting net assets of $1.93 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see VRPX company net worth.
Annual Tangible Net Worth Ratio for Virpax Pharmaceuticals Inc (2021–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Virpax Pharmaceuticals Inc from 2021 to 2023, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Virpax Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 100.0% | $1.93 Million | $0.00 | $9.63 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $16.58 Million | $0.00 | $19.67 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $37.48 Million | $0.00 | $39.57 Million | — |